🇯🇵·12h agoResearch
抗悪性腫瘍経口黄体ホルモン製剤「ヒスロンH錠200mg」の限定出荷に関するお詫びとお知らせ_第2報（協和キリン株式会社）
Publisher
J
Japanese Society of Medical Oncology
Japan
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on jsmo.or.jp
Leave the platform to read the original full article on the publisher site.
Source: Japanese Society of Medical Oncology
Scope: Research
Related coverage
More related coverage
AACR·3h ago
Stopping Cancer Before It Starts in Lynch Syndrome
Erasmus University Rotterdam·3h ago
Paul van Geest presents Erasmus University research to Pope Leo XIV in Rome
University of Edinburgh·4h ago
Teviot joins Pride Edinburgh celebrations
Japanese Society of Medical Oncology·4h ago